Article: Inamed Comments on FDA Talk Paper Comparing Effectiveness of Zyplast and Restylane.

Business Editors/Health/Medical Writers

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Dec. 16, 2003

Inamed Corporation (Nasdaq:IMDC):

-- Treatment Effect of Inamed's Zyplast(R) and of Restylane(R) as

Dermal Fillers Shown to be Comparable at Six Months

-- Overall Side Effect Profile of Zyplast shown to be better than

Restylane at Fourteen Days

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!